Brainmarc Ltd.
5
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Evaluation of Use of Brain Activity Monitoring for Evaluation of Depression Treatment
Role: lead
An Examination of the Use of Electrophysiological Brain Monitoring to Direct the Treatment of Mild Cognitive Impairment
Role: lead
Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.
Role: lead
Evaluation of Use of Brain Activity Monitoring for Prediction of Migraine Attacks
Role: lead
Evaluation of Use of Brain Activity Monitoring Dynamics in ADHD
Role: lead
All 5 trials loaded